Reme-D
Cairo, Egypt
◆ Total Raised
$1.4M
◆ Stage
pre-seed
◆ Location
Cairo, Egypt
◆ Founded
2022
◆ Team size
11-50
◆ Links
◆ About Reme-D
Egyptian healthtech startup that develops and manufactures molecular diagnostic tests for diseases including tuberculosis, HIV, hepatitis, and HPV.
◆ What sets it apart
Its diagnostic kits are designed to be affordable, locally manufactured, room-temperature stable, and usable in low-resource settings without reliance on imported kits.
◆ Sectors
◆ Business
Modelhardware
CustomerHealthcare providers, clinical laboratories, and diagnostic distributors serving low-resource settings
◆ Notable
- Named the Most Impactful Business by Mohammed Bin Rashid Innovation Fund
- Raised pre-Series A funding to scale commercially across Egypt, Kenya, and new markets
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Reme-D do?
Egyptian healthtech startup that develops and manufactures molecular diagnostic tests for diseases including tuberculosis, HIV, hepatitis, and HPV.
Where is Reme-D based?
Reme-D is based in Cairo, Egypt, founded in 2022.
How much has Reme-D raised?
Reme-D has raised $1.4M in tracked funding and is currently at the pre-seed stage.
Who has invested in Reme-D?
Investors in Reme-D include Oman Technology Fund, Mohammed Bin Rashid Innovation Fund, Global Innovation Fund, Anara Impact Capital, Africa Health Ventures, Techstars and VISA Middleast.